ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1541.HK)
HKD 5.36
(-1.83%)
HKD 5.36
(-1.83%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Total Assets | 874.59 Million | 839.97 Million | 892.83 Million |
| Total Current Assets | 686.7 Million | 651.87 Million | 704.09 Million |
| Cash And Short Term Investments | 608.56 Million | 635.21 Million | 668.32 Million |
| Cash and Cash Equivalents | 306.98 Million | 635.21 Million | 668.32 Million |
| Short Term Investments | 301.58 Million | - | - |
| Net Receivables | 39 Thousand | 66 Thousand | 34 Thousand |
| Inventory | 76.76 Million | 9.04 Million | 19.42 Million |
| Other Current Assets | 260.41 Million | 7.54 Million | 16.31 Million |
| Total Non-Current Assets | 187.89 Million | 188.1 Million | 188.73 Million |
| Net PPE | 83.92 Million | 173.74 Million | 167.45 Million |
| Good Will And Intangible Assets | 75.74 Million | 79.97 Million | 84.2 Million |
| Good Will | - | - | - |
| Intangible Assets | 75.74 Million | 79.97 Million | 84.2 Million |
| Long-Term Investments | -259.08 Million | - | - |
| Tax Assets | 248.8 Million | - | - |
| Other Non Current Assets | 38.5 Million | -65.6 Million | -62.91 Million |
| Other Assets | - | - | - |
| Total Liabilities | 126.3 Million | 60.75 Million | 2.49 Billion |
| Total Current Liabilities | 115.9 Million | 51.73 Million | 2.47 Billion |
| Account Payables | 10.8 Million | 1.26 Million | 1.76 Million |
| Tax Payables | 765 Thousand | 612 Thousand | 2.95 Million |
| Short Term Debt | 64.37 Million | 5.59 Million | 5.09 Million |
| Deferred Revenue | -4.39 Million | - | - |
| Other Current Liabilities | 45.12 Million | 44.87 Million | 2.47 Billion |
| Total Non Current Liabilities | 10.39 Million | 9.02 Million | 13.44 Million |
| Long-Term Debt | 10.39 Million | 9.02 Million | 13.44 Million |
| Deferred Revenue Non Current | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - |
| Other Non Current Liabilities | - | - | - |
| Other Liabilities | - | - | - |
| Total Equity | 748.28 Million | 779.22 Million | -1.59 Billion |
| Stock Holders Equity | 748.28 Million | 779.22 Million | -1.59 Billion |
| Common Stock | 374.15 Million | 356.09 Million | 6.9 Million |
| Retained Earnings | -710.34 Million | -330.88 Million | -1.63 Billion |
| Accumulated other comprehensive income | 374.12 Million | 99.54 Million | 32.23 Million |
| Common Stock Equity | 748.28 Million | 779.22 Million | -1.59 Billion |
| Capital Lease Obligation | 14.79 Million | 14.61 Million | 18.53 Million |
| Total Investments | 42.49 Million | - | - |
| Total Debt | 74.77 Million | 14.61 Million | 18.53 Million |
| Net Debt | -232.21 Million | -620.59 Million | -649.78 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Total Assets | 743.26 Million | 743.26 Million | 874.59 Million | 874.59 Million | 874.59 Million | 730.87 Million |
| Total Current Assets | 582.59 Million | 582.59 Million | 686.7 Million | 686.7 Million | 686.7 Million | 548.02 Million |
| Cash And Short Term Investments | 513.03 Million | 513.03 Million | 608.56 Million | 608.56 Million | 608.56 Million | 539.32 Million |
| Cash and Cash Equivalents | 246.84 Million | 246.84 Million | 306.98 Million | 306.98 Million | 306.98 Million | 495.96 Million |
| Short Term Investments | 266.18 Million | 266.18 Million | 301.58 Million | 301.58 Million | 42.49 Million | 43.35 Million |
| Net Receivables | 48 Thousand | 48 Thousand | 39 Thousand | 39 Thousand | 39 Thousand | 4000.00 |
| Inventory | 68.9 Million | 68.9 Million | 76.76 Million | 76.76 Million | 76.76 Million | 5.21 Million |
| Other Current Assets | 607 Thousand | 607 Thousand | 260.41 Million | 260.41 Million | 260.41 Million | 3.48 Million |
| Total Non-Current Assets | 160.67 Million | 160.67 Million | 187.89 Million | 187.89 Million | 187.89 Million | 182.85 Million |
| Net PPE | 116.96 Million | 116.96 Million | 83.92 Million | 83.92 Million | 149.38 Million | 153.24 Million |
| Good Will And Intangible Assets | - | - | 75.74 Million | 75.74 Million | - | - |
| Good Will | - | - | - | - | - | - |
| Intangible Assets | - | - | 75.74 Million | 75.74 Million | - | - |
| Long-Term Investments | - | - | -259.08 Million | -259.08 Million | - | - |
| Tax Assets | - | - | 248.8 Million | 248.8 Million | - | - |
| Other Non Current Assets | 43.7 Million | 43.7 Million | 38.5 Million | 38.5 Million | 38.5 Million | 29.61 Million |
| Other Assets | - | - | - | - | - | - |
| Total Liabilities | 143.02 Million | 143.02 Million | 126.3 Million | 126.3 Million | 126.3 Million | 80.79 Million |
| Total Current Liabilities | 119.77 Million | 119.77 Million | 115.9 Million | 115.9 Million | 115.9 Million | 73.99 Million |
| Account Payables | 4.88 Million | 4.88 Million | 10.8 Million | 10.8 Million | 10.8 Million | 436 Thousand |
| Tax Payables | - | - | 765 Thousand | 765 Thousand | - | 589 Thousand |
| Short Term Debt | 70.99 Million | 70.99 Million | 64.37 Million | 64.37 Million | 59.98 Million | 34.8 Million |
| Deferred Revenue | 36.46 Million | 36.46 Million | -4.39 Million | -4.39 Million | - | - |
| Other Current Liabilities | 7.43 Million | 43.9 Million | 45.12 Million | 45.12 Million | 45.12 Million | 38.74 Million |
| Total Non Current Liabilities | 23.25 Million | 23.25 Million | 10.39 Million | 10.39 Million | 10.39 Million | 6.8 Million |
| Long-Term Debt | 15 Million | 15 Million | 10.39 Million | 10.39 Million | 10.39 Million | 6.8 Million |
| Deferred Revenue Non Current | - | - | - | - | - | - |
| Deferred Tax Liabilities Non Current | - | - | - | - | - | - |
| Other Non Current Liabilities | 8.25 Million | 8.25 Million | - | - | - | - |
| Other Liabilities | - | - | - | - | - | - |
| Total Equity | 600.23 Million | 600.23 Million | 748.28 Million | 748.28 Million | 748.28 Million | 650.07 Million |
| Stock Holders Equity | 600.23 Million | 600.23 Million | 748.28 Million | 748.28 Million | 748.28 Million | 650.07 Million |
| Common Stock | 374.15 Million | 374.15 Million | 374.15 Million | 374.15 Million | 374.15 Million | 356.09 Million |
| Retained Earnings | -876.1 Million | -876.1 Million | -710.34 Million | -710.34 Million | -710.34 Million | -501.71 Million |
| Accumulated other comprehensive income | 188.72 Million | 188.72 Million | 374.12 Million | 374.12 Million | 171.01 Million | 141.22 Million |
| Common Stock Equity | 600.23 Million | 600.23 Million | 748.28 Million | 748.28 Million | 748.28 Million | 650.07 Million |
| Capital Lease Obligation | 11.71 Million | 11.71 Million | 14.79 Million | 14.79 Million | 14.79 Million | 11.63 Million |
| Total Investments | 266.18 Million | 266.18 Million | 42.49 Million | 42.49 Million | 42.49 Million | 43.35 Million |
| Total Debt | 85.99 Million | 85.99 Million | 74.77 Million | 74.77 Million | 70.37 Million | 41.61 Million |
| Net Debt | -160.85 Million | -160.85 Million | -232.21 Million | -232.21 Million | -236.6 Million | -454.35 Million |
3357
1907
002811
TSKB
082920
EIM